Genotype of thymidylate synthase likely to affect efficacy of adjuvant 5-FU based chemotherapy in colon cancer

Oncology Reports

Volumn 16, Issue 5, 2006, Pages 1111-1115

  Matsui, Takanori ^a   Omura, Kenji ^b   Kawakami, Kazuyuki ^b   Morita, Satoshi ^c   Sakamoto, Junichi ^c  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

Adjuvant chemotherapy; Colon cancer; DNA polymorphism; Prognosis; Prospective randomized clinical trial; Tandem repeat sequence; Thymidylate synthase

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL; KRESTIN; PROTEOGLYCAN; PS-K; THYMIDYLATE SYNTHASE;

AGED; ARTICLE; CLINICAL TRIAL; COLON TUMOR; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYMOLOGY; FEMALE; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HUMAN; MALE; METABOLISM; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COLONIC NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; FLUOROURACIL; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; PROTEOGLYCANS; THYMIDYLATE SYNTHASE;

EID: 34548751568     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.16.5.1111     Document Type: Article

References (23)

1. Danenberg PV and Lockshin A: Thymidylate synthetase - substrate complex formation. Mol Cell Biochem 43: 49-57, 1982.
2. Johnston PG, Fisher ER, Rockette HE, et al: The role of thymidylate synthase expression in prognosis and outcome of adjuvant chemotherapy in patients with rectal cancer. J Clin Oncol 12: 2640-2647, 1994. (Pubitemid 24379651)
3. Yamachika T, Nakanishi H, Inada K, et al: A new prognostic factor for colorectal carcinoma, thymidylate synthase and its therapeutic significance. Cancer 82: 70-77, 1998. (Pubitemid 28070481)
4. Takenoue T, Nagawa H, Matsuda K, et al: Relation between thymidylate synthase expression and survival in colon carcinoma and determination of appropriate application of 5-fluorouracil by immunohistochemical method. Ann Surg Oncol 7: 193-198, 2000. (Pubitemid 30215157)
5. Sakamoto J, Hamashima H, Suzuki H, et al: Thymidylate synthase expression as a predictor of the prognosis of curatively resected colon carcinoma in patients registered in an adjuvant immunochemotherapy clinical trial. Oncol Rep 10: 1081-1090, 2003.
6. Sanguedolce R, Vultaggio G, Sanguedolce F, et al: The role of thymidylate synthase levels in the prognosis and the treatment of patients with colorectal cancer. Anticancer Res 18: 1515-1520, 1998. (Pubitemid 28342553)
7. Cascinu S, Graziano F, Valentini M, et al: Vascular endothelial growth factor expression, S-phase fraction and thymidylate synthase quantitation in node-positive colon cancer: relationships with tumor recurrence and resistance to adjuvant chemotherapy. Ann Oncol 12: 239-244, 2001. (Pubitemid 32223875)
8. Tomiak A, Vincent M, Earle CC, et al: Thymidylate synthase expression in stage II and III colon cancer: a retrospective review. Am J Clin Oncol 24: 597-602, 2001. (Pubitemid 33131423)
9. Allegra CJ, Parr AL, Wold LE, et al: Investigation of the prognostic and predictive value of thymidylate synthase, p53 and Ki-67 in patients with locally advanced colon cancer. J Clin Oncol 20: 1735-1743, 2002. (Pubitemid 34273261)
10. Nanni O, Volpi A, Frassineti GL, et al: Role of biological markers in the clinical outcome of colon cancer. Br J Cancer 87: 868-875, 2002. (Pubitemid 35252962)
11. Horie N, Aiba H, Oguro K, et al: Functional analysis and DNA polymorphism of the tandemly repeated sequences in the 5′-terminal regulatory region of the human gene for thymidylate synthase. Cell Struct Funct 20: 191-197, 1995.
12. Kawakami K, Omura K, Kanehira E, et al: Polymorphic tandem repeats in the thymidylate synthase gene is associated with its protein expression in human gastrointestinal cancers. Anticancer Res 19: 3249-3252, 1999. (Pubitemid 30042617)
13. Ito K, Nakazato H, Koike A, et al: Long-term effect of 5-fluorouracil enhanced by intermittent administration of polysaccharide K after curative resection of colon cancer. A randomized controlled trial for 7-year follow-up. Int J Colorectal Dis 19: 157-164, 2004. (Pubitemid 38239838)
14. Van Triest B, Pinedo HM, Blaauwgeers JL, et al: Prognostic role of thymidylate synthase, thymidine phosphorylase/platelet-derived endothelial cell growth factor, and proliferation markers in colorectal cancer. Clin Cancer Res 6: 1063-1072, 2000. (Pubitemid 30159368)
15. Kornmann M, Link KH, Galuba I, et al: Association of time to recurrence with thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression in stage II and III colorectal cancer. J Gastrointest Surg 6: 331-337, 2002. (Pubitemid 40433535)
16. Van der Wilt CL, Pinedo HM, Smid K, et al: Elevation of thymidylate synthase following 5-fluorouracil treatment is prevented by the addition of leucovorin in murine colon tumors. Cancer Res 52: 4922-4928, 1992.
17. Peters GJ, van der Wilt CL, van Groeningen CJ, et al: Thymidylate synthase inhibition after administration of fluorouracil with or without leucovorin in colon cancer patients: implications for treatment with fluorouracil. J Clin Oncol 12: 2035-2042, 1994. (Pubitemid 24356018)
18. Omura K, Kawakami K, Kanehira E, et al: The number of 5-fluoro-2′-deoxyuridine-5′-monophosphate binding sites and reduced folate pool in human colorectal carcinoma tissues: changes after tegafur and uracil treatment. Cancer Res 55: 3897-3901, 1995.
19. Kawakami K, Salonga D, Park JM, et al: Different lengths of a polymorphic repeat sequence in the thymidylate synthase gene affect translational efficiency but not its gene expression. Clin Cancer Res 7: 4096-4101, 2001. (Pubitemid 34044633)
20. Pullarkat ST, Stoehlmacher J, Ghaderi V, et al: Thymidylate synthase gene polymorphism determines response and toxicity of 5-FU chemotherapy. Pharmacogenomics J 1: 65-70, 2001. (Pubitemid 33757985)
21. Iacopetta B, Grieu F, Joseph D, et al: A polymorphism in the enhancer region of the thymidylate synthase promoter influences the survival of colorectal cancer patients treated with 5-fluorouracil. Br J Cancer 85: 827-830, 2001. (Pubitemid 33010548)
22. Lecomte T, Ferraz JM, Zinzindohoue F, et al: Thymidylate synthase gene polymorphism predicts toxicity in colorectal cancer patients receiving 5-fluorouracil-based chemotherapy. Clin Cancer Res 10: 5880-5888, 2004. (Pubitemid 39180969)
23. Jakobsen A, Nielsen JN, Gyldenkerne N, et al: Thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphism in normal tissue as predictors of fluorouracil sensitivity. J Clin Oncol 23: 1365-1369, 2005.